Teva Pharmaceutical Industries News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.10.13	Awareness Programs, Restructuring Efforts, Conference Calls, Marketing Authorization Withdrawal and Clinical Trial Commencement - Research Report on Lilly, Teva, Elan, Zoetis, and Boston Scientific (PR Newswire)
14.10.13	Teva Receives FDA Approval For Generic Version Of TOBI - Quick Facts (RTTNews)
10.10.13	Pre-market Movers For Oct 10 (AAPL, SIRI, CAFI, TEVA, PVR, IGTE, CTXS, RT) (RTTNews)
10.10.13	Teva To Cut 5000 Jobs, Sees $2 Bln In Annual Cost Savings By 2017 (RTTNews)
10.10.13	Teva To Cut 5,000 Jobs Globally - Quick Facts (RTTNews)
04.10.13	Teva Presents Additional Analyses Of Late-stage Allegro And Bravo Studies (RTTNews)
03.10.13	Teva Reports Further Results From Long-term, Open-label Extension Study Of GA (RTTNews)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
27.09.13	Under AAAResearchReports.com Microscope: Zoetis Inc., Teva Pharma Industries Ltd, Covidien PLC, and Valeant Pharma Intl. Inc. (PR Newswire)
26.09.13	FDA Approvals, New Appointments, Positive Litigation Outcomes and Partnerships - Research Report on Edwards Lifesciences, Illumina, Teva, Alere, and Dr. Reddy's (PR Newswire)
24.09.13	Teva Announces Quartette™ (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets Now Available for the Prevention of Pregnancy in the United States (PR Newswire)
24.09.13	Teva Pharma Launches Generic ADENOSCAN In US - Quick Facts (RTTNews)
23.09.13	Teva Wins Azilect Patent Dispute Against Mylan - Quick Facts (RTTNews)
19.09.13	Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter (PR Newswire)
17.09.13	Teva's TREANDA Injection Gets FDA Approval - Quick Facts (RTTNews)
16.09.13	Teva, Cancer Research Technology Sign R&D Alliance Agreement - Quick Facts (RTTNews)
29.08.13	AEZS Shifts Listing, AUXL Gets New Decision Date, Teva Hangs Up On RNN Deal (RTTNews)
28.08.13	Rexahn Pharma: Teva Decides Not To Exercise Its Option To License RX-3117 (RTTNews)
21.08.13	Technical Study: Zoetis Inc., Teva Pharma Industries Ltd, Covidien plc, and Valeant Pharma Intl. Inc. (PR Newswire)
12.08.13	Teva Pharma, Perrigo Announce U.S. Launch Of Generic Temozolomide - Quick Facts (RTTNews)
12.08.13	Financial Results Release, Management Changes, and Newly Issued Permits - Research Report on Valeant, Teva, Endo, Array, and Sequenom (PR Newswire)
09.08.13	Critical Alerts For Amazon, Teva Pharmaceuticals, Charles Schwab, VMware, and Level 3 Communications Released By InvestorsObserver (PR Newswire)
06.08.13	Strong Sales, Diversified Portfolio, and R&D Progress Boost Growth - Research Report on Teva, Auxilium, Nektar, Anika, and Vical (PR Newswire)
01.08.13	Teva Q2 Profit Meets Estimates, While Mylan Profit Beats View; But Revenues Miss (RTTNews)
01.08.13	Teva Q2 Adj. Profit Matches View, But Revenues Miss - Quick Facts (RTTNews)
01.08.13	Earnings Watch For August 1 (CAH, PG, KRFT, COP, XOM, LNKD) (RTTNews)
29.07.13	English Appeal Court Rules In Favor Of Teva In Copaxone Patent Case (RTTNews)
25.07.13	Teva, Lonza To Discontinue Biosimilars Collaboration (RTTNews)
23.07.13	FDA Designations to Development Programs and Quarterly Financial Results Schedules - Research Report on Valeant, Elan, Alkermes, Teva and Gilead (PR Newswire)
18.07.13	Teva Found On Summary Judgment To Infringe Mylan Patent For Perforomist (RTTNews)
18.03.10	Teva to Acquire ratiopharm (Businesswire)
17.03.10	Teva Provides Update on Generic Temodar® (Businesswire)
22.01.10	Court of Appeals Affirms Favorable Decision Regarding Generic Prevacid® SoluTab (Businesswire)
07.01.10	Teva Announces Settlement Agreements with AstraZeneca Regarding Generic Prilosec® and Nexium® (Businesswire)
10.09.09	COPAXONE® Significantly Reduced Disease Severity in Long-Term Treated Multiple Sclerosis Patients (Businesswire)
08.09.09	New Teva Data Highlights Advances in MS Treatment Research (Businesswire)
13.07.09	Plan B® One-Step—New FDA-Approved One-Pill Emergency Contraceptive (Businesswire)
02.04.09	Teva Introduces First Generic Adderall XR® Capsules in the United States (Businesswire)
17.03.09	Study Demonstrates That QVAR® is More Likely to Achieve Successful Asthma Control with Less Exacerbations (Businesswire)
17.02.09	Teva Reports Record Full Year 2008 and Fourth Quarter Results (Businesswire)
12.02.09	Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA (Businesswire)
27.01.09	Teva to Report Fourth Quarter and Full Year 2008 Financial Results on February 17, 2009 (Businesswire)
18.11.08	Economist Finds Flaws in 14-Year Data Exclusivity Claim for Biogenerics (Businesswire)
18.11.08	Teva Completes Enrollment in Laquinimod Phase III Clinical Trial (Businesswire)
07.11.08	Teva Provides Update on Generic Prevacid(R) Litigation (Businesswire)
23.09.08	Teva's ProAir(R) HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication (Businesswire)
18.09.08	Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R) (Businesswire)
12.05.08	Teva to Present at the Bank of America Health Care Conference (Businesswire)
06.05.08	Teva Reports First Quarter 2008 Results (Businesswire)
31.03.08	Teva Provides Update on Generic Prevacid(R) Litigation (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold